
Topical ruxolitinib shows efficacy and safety in dermatological conditions.


coremsg

This review summarizes the use of topical ruxolitinib, a JAK inhibitor, in various dermatological conditions including vitiligo, alopecia areata, atopic dermatitis, psoriasis, and more.

Utilization of Topical Ruxolitinib in Dermatology

utilization-of-topical-ruxolitinib-in-dermatology-efficacy-and-safety-review


Utilization of Topical Ruxolitinib in Dermatology: Efficacy and Safety Review
